Search research articles
Contact Us
Filters
Showing results (1-10 of 27) with videos related to
Page
of 3
Sort By:
Current Opinion in HIV and AIDS
|
April 18, 2009
Update on HIV-1 viral load blips
Richard E Nettles, Tara L Kieffer
The Journal of Antimicrobial Chemotherapy
|
March 15, 2006
HIV-1 viral load blips are of limited clinical significance
Patricia K Lee, Tara L Kieffer, Robert F Siliciano, et al.
Reviews on Recent Clinical Trials
|
April 14, 2017
Treating Older HIV-1-infected Subjects With Cobicistat-boosted Darunavir in a 48-week Phase 3 Trial
Kimberley Brown, Brooke Patterson-Browning, Chris Liu, et al.
AIDS Research and Human Retroviruses
|
August 28, 2018
Prevalence of Darunavir Resistance in the United States from 2010 to 2017
Kimberley Brown, Lisa Stewart, Jeannette M Whitcomb, et al.
AIDS Research and Human Retroviruses
|
June 7, 2019
Trends in HIV-1 Drug Resistance Mutations from a U.S. Reference Laboratory from 2006 to 2017
Ron M Kagan, Keith J Dunn, Gregg P Snell, et al.
Journal of Virology
|
January 15, 2005
G-->A hypermutation in protease and reverse transcriptase regions of human immunodeficiency virus type 1 residing in resting CD4+ T cells in vivo
Tara L Kieffer, Patty Kwon, Richard E Nettles, et al.
Clinical Pharmacology in Drug Development
|
December 4, 2018
Impact of Splitting or Crushing on the Relative Bioavailability of the Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Single-Tablet Regimen
Kimberley Brown, David Thomas, Kevin McKenney, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
February 5, 2003
Successful treatment of Trichosporon mucoides infection with fluconazole in a heart and kidney transplant recipient
Richard E Nettles, Lynette S Nichols, Katherine Bell-McGuinn, et al.
Journal of Pharmaceutical Sciences
|
May 18, 2013
Compartmental absorption modeling and site of absorption studies to determine feasibility of an extended-release formulation of an HIV-1 attachment inhibitor phosphate ester prodrug
Jonathan Brown, Caly Chien, Peter Timmins, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
October 9, 2004
Genotypic resistance in HIV-1-infected patients with persistently detectable low-level viremia while receiving highly active antiretroviral therapy
Richard E Nettles, Tara L Kieffer, Rachel P Simmons, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 27) with videos related to
Sort By:
Page
of 3
Current Opinion in HIV and AIDS
|
April 18, 2009
Update on HIV-1 viral load blips
Richard E Nettles, Tara L Kieffer
The Journal of Antimicrobial Chemotherapy
|
March 15, 2006
HIV-1 viral load blips are of limited clinical significance
Patricia K Lee, Tara L Kieffer, Robert F Siliciano, et al.
Reviews on Recent Clinical Trials
|
April 14, 2017
Treating Older HIV-1-infected Subjects With Cobicistat-boosted Darunavir in a 48-week Phase 3 Trial
Kimberley Brown, Brooke Patterson-Browning, Chris Liu, et al.
AIDS Research and Human Retroviruses
|
August 28, 2018
Prevalence of Darunavir Resistance in the United States from 2010 to 2017
Kimberley Brown, Lisa Stewart, Jeannette M Whitcomb, et al.
AIDS Research and Human Retroviruses
|
June 7, 2019
Trends in HIV-1 Drug Resistance Mutations from a U.S. Reference Laboratory from 2006 to 2017
Ron M Kagan, Keith J Dunn, Gregg P Snell, et al.
Journal of Virology
|
January 15, 2005
G-->A hypermutation in protease and reverse transcriptase regions of human immunodeficiency virus type 1 residing in resting CD4+ T cells in vivo
Tara L Kieffer, Patty Kwon, Richard E Nettles, et al.
Clinical Pharmacology in Drug Development
|
December 4, 2018
Impact of Splitting or Crushing on the Relative Bioavailability of the Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Single-Tablet Regimen
Kimberley Brown, David Thomas, Kevin McKenney, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
February 5, 2003
Successful treatment of Trichosporon mucoides infection with fluconazole in a heart and kidney transplant recipient
Richard E Nettles, Lynette S Nichols, Katherine Bell-McGuinn, et al.
Journal of Pharmaceutical Sciences
|
May 18, 2013
Compartmental absorption modeling and site of absorption studies to determine feasibility of an extended-release formulation of an HIV-1 attachment inhibitor phosphate ester prodrug
Jonathan Brown, Caly Chien, Peter Timmins, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
October 9, 2004
Genotypic resistance in HIV-1-infected patients with persistently detectable low-level viremia while receiving highly active antiretroviral therapy
Richard E Nettles, Tara L Kieffer, Rachel P Simmons, et al.
Page
of 3